Treatment with Toll-like Receptor (TLR) Ligands 3 and 21 Prevents Fecal Contact Transmission of Low Pathogenic H9N2 Avian Influenza Virus (AIV) in Chickens
Viruses · 16.04.2023 · 15 (4) · 977
DOI: 10.3390/v15040977 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 16.04.2023. Verfasst von Sugandha Raj und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada. Hauptthemen laut MEDLINE: Influenza A Virus, H9N2 Subtype, Influenza in Birds, Poultry Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Biotechnology and Biological Sciences Research Council, Ontario Ministry of Agriculture, Food and Rural Affairs.
Abstract (Originalsprache)
Transmission of H9N2 avian influenza virus (AIV) can occur in poultry by direct or indirect contact with infected individuals, aerosols, large droplets and fomites. The current study investigated the potential of H9N2 AIV transmission in chickens via a fecal route. Transmission was monitored by exposing naïve chickens to fecal material from H9N2 AIV-infected chickens (model A) and experimentally spiked feces (model B). The control chickens received H9N2 AIV. Results revealed that H9N2 AIV could persist in feces for up to 60–84 h post-exposure (PE). The H9N2 AIV titers in feces were higher at a basic to neutral pH. A higher virus shedding was observed in the exposed chickens of model B compared to model A. We further addressed the efficacy of Toll-like receptor (TLR) ligands to limit transmission in the fecal model. Administration of CpG ODN 2007 or poly(I:C) alone or in combination led to an overall decrease in the virus shedding, with enhanced expression of type I and II interferons (IFNs) and interferon-stimulating genes (ISGs) in different segments of the small intestine. Overall, the study highlighted that the H9N2 AIV can survive in feces and transmit to healthy naïve chickens. Moreover, TLR ligands could be applied to transmission studies to enhance antiviral immunity and reduce H9N2 AIV shedding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.
- Sunnybrook Research Institute, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M4N 3M5, Canada.
- The Pirbright Institute, Pirbright, Woking GU24 0NE, Surrey, UK.
ORCID-Profile: Mohammadali Alizadeh, Khalil Karimi
Förderung
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council
- Ontario Ministry of Agriculture, Food and Rural Affairs
- Natural Sciences and Engineering Research Council of Canada (NSERC)
- Chicken Farmers of Saskatchewan
- Egg Farmers of Canada
- Canadian Poultry Research Council
- University of Guelph’s Food
Zitieren
APA
Raj, S., Matsuyama-Kato, A., Alizadeh, M., Boodhoo, N., Nagy, E., Mubareka, S., Karimi, K., Behboudi, S., & Sharif, S. (2023). Treatment with Toll-like Receptor (TLR) Ligands 3 and 21 Prevents Fecal Contact Transmission of Low Pathogenic H9N2 Avian Influenza Virus (AIV) in Chickens. Viruses, 15(4), 977. https://doi.org/10.3390/v15040977
Vancouver
Raj S, Matsuyama-Kato A, Alizadeh M, Boodhoo N, Nagy E, Mubareka S, et al. Treatment with Toll-like Receptor (TLR) Ligands 3 and 21 Prevents Fecal Contact Transmission of Low Pathogenic H9N2 Avian Influenza Virus (AIV) in Chickens. Viruses. 2023;15(4):977. doi:10.3390/v15040977
BibTeX
@article{Raj2023,
author = {Raj, Sugandha and Matsuyama-Kato, Ayumi and Alizadeh, Mohammadali and Boodhoo, Nitish and Nagy, Eva and Mubareka, Samira and Karimi, Khalil and Behboudi, Shahriar and Sharif, Shayan},
title = {Treatment with Toll-like Receptor (TLR) Ligands 3 and 21 Prevents Fecal Contact Transmission of Low Pathogenic H9N2 Avian Influenza Virus (AIV) in Chickens},
journal = {Viruses},
year = {2023},
volume = {15},
number = {4},
pages = {977},
doi = {10.3390/v15040977}
}
EUVIMED